Materials & Methods: Anhydrous CH 2 Cl 2 was purchased from EMD chemicals and stored over 4Å molecular sieves, prior to use. Anhydrous toluene was obtained from Alfa Aesar and used as received. (iPr) 2 EtN (Hünig's base) was obtained from Sigma-Aldrich. All protected DNA and RNA monomers were obtained from Chem-Impex International, Inc. and used as received. 2-cyanoethyl-N,N,-diisopropyl chlorophosphoramidite 5 was obtained from Rasayn Inc. 2-cyanoethyl-N,N,N',N'-tetraisopropyl phosphorodiamidite 6 was obtained from ChemGenes Corporation. Pre-coated flexible silica gel TLC F254 plates were obtained from Whatman Ltd. Flash column chromatography was performed using silica gel 60 (40-60 µm) from Fisher Scientific.
600 equipped with a 5 mm DCH cryoprobe at 150 MHz for carbon referenced to CDCl 3 at 77.23 ppm. 31 P NMR chemical shifts were recorded in ppm relative to an external probe (85% H 3 PO 4 ) referenced at 0.0 ppm. Mass analysis was performed using Agilent ESI-TOF mass spectrometer at an ESI voltage of 4000V and a flow rate of 200 µL/minute. Microwave assisted synthesis was performed on a Microwave synthesizer Biotage initiator EXP US (in K. B. Sharpless lab at TSRI). Electronic Supplementary Material (ESI) for Chemical Communications. This journal is © The Royal Society of Chemistry 2014
4ʹ′-O-benzoyl-1ʹ′-O-(4,4'-dimethoxytrityl)-β-L-ribulofuranosylthymine-2ʹ′-[(2-cyanoethyl)-(N,Ndiisopropyl)]-phosphoramidite (7):
4ʹ′-O-benzoyl-1ʹ′-O-(4,4ʹ′-dimethoxytrityl)-β-Lribulofuranosylthymine 3 (0.318 g, 0.48 mmol) was azeotroped with anhydrous toluene (3 x 20 mL) and dried under high vacuum overnight. It was further dissolved in 5 mL of anhydrous CH 2 Cl 2 , followed by the addition of (iPr) 2 EtN (0.47 mL, 2.87 mmol) under argon atmosphere. The solution was cooled to 0 °C, followed by the addition of 2-cyanoethyl-N,N,-diisopropyl chlorophosphoramidite 5 (0.21 mL, 0.95 mmol). The reaction mixture was brought to room temperature and stirred overnight. The reaction mixture was quenched by the addition of saturated aq. NaHCO 3 (5 mL) solution, extracted with CH 2 Cl 2 (3 x 50 mL), washed with water (20 mL) followed by brine (50 mL). The combined organic extract was dried over anhydrous MgSO 4 , filtered, concentrated in vacuo, and the residue was purified by silica gel column chromatography (30% EtOAc/hexanes containing 2% Et 3 N) to afford 0. Figure S1 .
1 H NMR of protected β-L-ribulo-T-phosphoramidite derivative 7 in CDCl 3 Figure S2 . 31 P NMR of protected L-ribulo-T-phosphoramidite 7 in CDCl 3 Figure S3 .
1ʹ′-dimethoxytrityl-4ʹ′-O-triisopropylsilyloxymethyl-L-ribulofuranosylthymine 4 (0.550 g, 0.74 mmol) was azeotroped with anhydrous toluene (3 x 20 mL), dried under high vacuum overnight, and dissolved in 3 mL of anhydrous CH 2 Cl 2 , followed by the addition of (iPr) 2 EtN (0.48 mL, 2.96 mmol) under argon atmosphere. The resulting solution was transferred to a microwave tube (2-5 mL) containing 2-cyanoethyl-N,N,-diisopropyl chlorophosphoramidite 5 (0.33 mL, 1.48 mmol). Microwave tube was sealed and irradiated at 65 °C for 20 min. The reaction mixture was quenched by the addition of saturated aq. NaHCO 3 (5 mL) solution, extracted with CH 2 Cl 2 (3 x 50 mL), washed with water (20 mL) followed by brine (50 mL), and the combined organic extract was dried over anhydrous MgSO 4 , filtered and concentrated in vacuo. The residue was purified by silica gel column chromatography (30% EtOAc/hexanes containing 2% Et 3 N) to afford 0.526 g (75%) of pure phosphoramidite 8 as a white amorphous solid (mixture of diastereomers in ratio of 2:1). 
N6-benzoyl-1'-O-dimethoxytrityl-4'-O-triisopropylsilyloxymethyl-β-L-ribulofuranosyl-adenine-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite (12)
: DMT-protected nucleoside 9 (300 mg, 0.35 mmol) was dried by coevaporation with toluene (3 x 20 mL) and further dissolved in anhydrous CH 2 Cl 2 (2.57 mL), followed by the addition of (iPr) 2 EtN (238 µL, 1.40 mmol, 4 eq.). 2-cyanoethyl-N,N,-diisopropyl chlorophosphoramidite 5 (157 µL, 0.70 mmol, 2.0 eq.) was added to the stirred solution and irradiated in a microwave reactor at 65 °C for 1 h. The reaction mixture was cooled to 0 °C and quenched by the addition of saturated aqueous NaHCO 3 (3 mL) solution. The reaction mixture was partitioned between CH 2 Cl 2 (50 mL) and saturated aqueous NaHCO 3 (30 mL). Then, the aqueous layer was extracted with CH 2 Cl 2 (3 x 50 mL). The organic extracts were combined and washed with brine (20 mL) and dried over anhydrous MgSO 4 , filtered and concentrated in vacuo. The crude product was purified by silica gel flash column chromatography (hexanes/EtOAc 2:1 (2% Et 3 N) à hexanes/EtOAc 3:2 (2% Et 3 N)) to afford compound 12 as a white foam (256 mg, 0.24 mmol, 69% yield). 12: R f : 0.44 (hexanes/EtOAc 2:1 
N4-benzoyl-1'-O-dimethoxytrityl-4'-O-triisopropylsilyloxymethyl-β-L-ribulofuranosyl-cytosine-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite (13)
. DMT-protected nucleoside 10 (287 mg, 0.34 mmol) was dried by co-evaporation with toluene (3 x 10 mL) and dissolved in anhydrous CH 2 Cl 2 (2.5 mL) followed by the addition of (iPr) 2 EtN (231.5 µL, 4 eq.). 2-cyanoethyl-N,N,-diisopropyl chlorophosphoramidite 5 (152.2 µL, 2.0 eq.) was added to the stirred solution and irradiated in a microwave reactor at 65 °C for 1 h. Saturated aqueous NaHCO 3 (3 mL) solution was added to quench the reaction at room temperature. The mixture was partitioned between CH 2 Cl 2 (50 mL) and saturated aqueous NaHCO 3 (30 mL). Then, the aqueous layer was extracted with CH 2 Cl 2 (3 x 50 mL). The combined organic extract was washed with brine (20 mL), dried over anhydrous MgSO 4 , filtered and concentrated in vacuo. The crude product was purified by silica gel flash chromatography (hexanes/EtOAc 2:1 (2% Et 3 N) à hexanes/EtOAc 3:2 (2% Et 3 N)) to yield compound 13 as white foam (261 mg, 74% yield, 2:1 diasteromers). Figure S12. 13 C NMR of 13 in CDCl 3 Figure S13 . 31 Figure S14 . HRMS (ESI-TOF high-accu) of phosphoramidite 13
N2-acetyl-1'-O-dimethoxytrityl-4'-O-triisopropylsilyloxymethyl-β-L-ribulofuranosyl-guanine-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite (14)
. DMT-protected nucleoside 11 (50 mg, 49.5 µmol) was dried by co-evaporation with toluene (3 x 10 mL) and dissolved in anhydrous CH 2 Cl 2 (500 µL) followed by the addition of (iPr) 2 EtN (34.5 µL, 198.2 µmol). To this solution was added 2-cyanoethyl-N,N,-diisopropyl chlorophosphoramidite 5 (22.1 µL, 99.1 µmol), followed by a catalytic amount of dimethylaminopyridine (DMAP) (3 mg, 24.8 µmol), and this solution was irradiated in a microwave reactor at 65 °C for 1 h. After cooling the reaction on ice, it was quenched with saturated aqueous NaHCO 3 (1 mL). This mixture was partitioned between CH 2 Cl 2 (10 mL) and saturated aqueous NaHCO 3 (5 mL). Then, the aqueous layer was back-extracted with CH 2 Cl 2 (2 x 5 mL). The combined organic extracts were then washed with brine (5 mL), dried over anhydrous Na 2 SO 4 , and concentrated in vacuo. The crude product was purified by silica gel flash chromatography using a gradient of 3:7 à 6:4 EtOAc/hex containing 2% Et 3 N to yield compound 14 as a white foam (30 mg, 50% yield) and a mixture of diastereomers. Data for 14: 
1ʹ′O-(4,4ʹ′-dimethoxytrityl)-3ʹ′-O-tri-isopropylsilyloxymethyl-L-ribulofuranosylthymine-4ʹ′-O-[O-(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite (16):
Ribulofuranosylthymine 15 (0.070 g, 0.094 mmol) was azeotroped with anhydrous toluene (3 x 5 mL),dried under high vacuum overnight, and further taken up in of anhydrous CH 2 Cl 2 (1 mL), followed by the addition of (iPr) 2 EtN (0.08 mL, 0.47 mmol) under argon atmosphere. This solution was transferred to a microwave tube (2-5 mL) containing 2-cyanoethyl-N,N,-diisopropyl chlorophosphoramidite 5 (0.04 mL, 0.19 mmol). The microwave tube was sealed and irradiated at 65 °C for 15 min. The reaction mixture was quenched by the addition of saturated NaHCO 3 (5 mL) solution, extracted with CH 2 Cl 2 (3 x 50 mL), washed with water (20 mL) followed by brine (50 mL) and dried over anhydrous MgSO 4 . The resulting solution was filtered and concentrated in vacuo. The crude product was purified by silica gel column chromatography (30% EtOAc/hexanes containing 2% Et 3 N) to afford 0.069 g (78%) of pure phosphoramidite 16 as a white amorphous solid (mixture of diastereomers in ratio of 2:1). DNA and RNA phosphoramidites: The optimized procedures developed for the ribulonucleoside series (see above) was used for the synthesis of the DNA and RNA phosphoramidites. Since the reaction temperature, reaction time and solvent was optimized with the ribulosenucleosides, and worked well in the DNA/RNA series, we did not have the need to optimize these parameters further, except with respect to the different activators as noted in Table S2 . Only in the case of guanosine 24 (RNA) 10 min at 60 °C was explored.
General procedure for synthesizing both DNA and RNA phosphoramidites via microwave using reagents 5 or 6: DNA and RNA monomers 17-20 and 21-24 (0.5 mmol) were dissolved in anhydrous CH 2 Cl 2 (3 mL), followed by the addition of 2-cyanoethyl-N,N-diisopropyl chlorophosphoramidite 5 (0.65 mmol) with diisopropylethylamine (1.30 mmol), or 2-cyanoethyl-N,N,Nʹ′,Nʹ′-tetraisopropyl phosphorodiamidite 6 (0.65 mmol) with activators 5-ethylthiotetrazole (0.65 mmol), or pyridinium chloride (0.65 mmol) under argon atmosphere in a microwave tube. The tube was sealed and irradiated at 65 °C while stirring for 15 min. The reaction mixture was concentrated to dryness and directly loaded on silica gel for purification by column chromatography (elution with 30%-80% EtOAc/hexanes containing 2% Et 3 N) to afford the corresponding DNA and RNA phosphoramidites, 25-28 and 29-32 respectively. 
N6-benzoyl-5ʹ′-O-(4,4ʹ′-dimethoxytrityl)-2ʹ′-deoxyadenosine-3ʹ′-O-[O-(2-cyanoethyl)-N,N-

N2-isobutyryl-5ʹ′-O-(4,4ʹ′-dimethoxytrityl)-2ʹ′-deoxyguanine-3ʹ′-O-[O-(2-cyanoethyl)-N,N-
5ʹ′-O-(4,4ʹ′-dimethoxytrityl)-2ʹ′-O-tertbutyl(dimethylsilyl)uracil-3ʹ′-O-[O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite
N6-benzoyl-5ʹ′-O-(4,4ʹ′-dimethoxytrityl)-2ʹ′-O-tertbutyl(dimethylsilyl)adenine-3ʹ′-O-[O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite
N4-acetyl-5ʹ′-O-(4,4ʹ′-dimethoxytrityl)-2ʹ′-O-tertbutyl(dimethylsilyl)cytidine-3ʹ′-O-[O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite
N2-isobutyryl-5ʹ′-O-(4,4ʹ′-dimethoxytrityl)-2ʹ′-O-tertbutyl(dimethylsilyl)guanine-3ʹ′-O-[O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite
